These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1048 related articles for article (PubMed ID: 28135901)

  • 1. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal Nanotechnology for Cancer Theranostics.
    Yue X; Dai Z
    Curr Med Chem; 2018; 25(12):1397-1408. PubMed ID: 28266269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The upcoming field of theranostic nanomedicine: an overview.
    Prabhu P; Patravale V
    J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards tailored management of malignant brain tumors with nanotheranostics.
    Aparicio-Blanco J; Torres-Suárez AI
    Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.
    Muthu MS; Feng SS
    Expert Opin Drug Deliv; 2013 Feb; 10(2):151-5. PubMed ID: 23061654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics.
    Sonali ; Singh RP; Singh N; Sharma G; Vijayakumar MR; Koch B; Singh S; Singh U; Dash D; Pandey BL; Muthu MS
    Drug Deliv; 2016 May; 23(4):1261-71. PubMed ID: 26961144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.
    Seleci M; Ag Seleci D; Scheper T; Stahl F
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interlocked systems in nanomedicine.
    Ornelas-Megiatto C; Becher TB; Megiatto JD
    Curr Top Med Chem; 2015; 15(13):1236-56. PubMed ID: 25858133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics.
    Muthu MS; Leong DT; Mei L; Feng SS
    Theranostics; 2014; 4(6):660-77. PubMed ID: 24723986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.
    Caldorera-Moore ME; Liechty WB; Peppas NA
    Acc Chem Res; 2011 Oct; 44(10):1061-70. PubMed ID: 21932809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGD-TPGS decorated theranostic liposomes for brain targeted delivery.
    Sonali ; Singh RP; Sharma G; Kumari L; Koch B; Singh S; Bharti S; Rajinikanth PS; Pandey BL; Muthu MS
    Colloids Surf B Biointerfaces; 2016 Nov; 147():129-141. PubMed ID: 27497076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized magnetic nanoparticles for biomedical applications.
    Gudovan D; Balaure PC; Mihăiescu DE; Fudulu A; Purcăreanu B; Radu M
    Curr Pharm Des; 2015; 21(42):6038-54. PubMed ID: 26503153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotheranostics, a future remedy of neurological disorders.
    Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
    Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
    Lammers T; Kiessling F; Hennink WE; Storm G
    Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.